OCS-Plus
Background
The OCS-Plus was developed as an elaboration of the domain specific OCS, to detect more subtle cognitive changes, which may otherwise be missed. The OCS-Plus was conceived as a computerised tablet-based screen of finer-grained tests of domain-general cognition, including various aspects of memory and executive attention.
The aim of OCS-Plus was to sensitively pick up on domain general impairments in healthy ageing, mild cognitive impairment and vascular dementia, without undue loading of language requirements. The OCS-Plus specifically allows differentiation of memory and non-memory impairments.
OCS plus was normed and validated in healthy ageing cohorts in the UK and Germany (Demeyere et al 2021) and has been used in epidemiological research in low-literacy settings (e.g. Humphreys et al 2017).
The OCS-Plus was recently validated for use in stroke (Webb et al, 2022).
Key Publications